Skip to main content

Latest News

April 2022

New GMP-grade Recombinant Human IL-15 is available, produced in our new GMP manufacturing facility. GMP IL-15 pairs with our GMP IL-7 for ex vivo expansion of CAR-T and TCR cell therapies.

January 2022

Our New T Cell-Based Therapies eBook lays out some of the major biological and manufacturing challenges facing the industry today. It follows up with examples of how Bio-Techne products and services address these challenges at each stage of the process.

Our New FlowX Human NK Cell Killing Flow Cytometry Kit analyzes the capability of NK and NK-CAR cells to target and kill cells of interest. The assay is based on direct detection of LAMP proteins and does not require the use of radioactive labels.

Our New FlowX Human NK Cell Phenotyping Flow Cytometry Kit enables the single-step analysis of expanded human NK cells. It contains 6 fluorochrome-conjugated antibodies and 6 isotype controls, plus staining buffer.

Our new page, Transitioning to Animal-Free and GMP, walks you through how we help you advance your program to the clinic as easily as possible. The page includes data showing how you can expect equivalent bioactivity from our reagents regardless of the grade.

New GMP-grade Recombinant Human IL-10. This is the first commercially available GMP version of human IL-10, and we produce it in our new GMP manufacturing facility.

Bio-Techne and Akoya Biosciences announce their partnership to deliver an Automated Spatial Multiomics workflow with industry-leading speed and resolution. Bio-Techne's RNAScope technology combined with Akoya's PhenoCycler-Fusion system will enable comprehensive spatial phenotyping of RNA and protein biomarkers.